Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details Narrative)

SUBSEQUENT EVENTS (Details Narrative)						1 Months Ended	12 Months Ended
SUBSEQUENT EVENTS (Details Narrative)	Feb. 08, 2024 USD ($) Days	Feb. 02, 2024 USD ($)	Jan. 31, 2024 $ / shares shares	Jan. 29, 2024 USD ($)	Jan. 01, 2024 shares	Apr. 30, 2014	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Mar. 06, 2024 USD ($) $ / shares shares	Jun. 13, 2023 USD ($)	Jan. 01, 2023 shares
Subsequent Event [Line Items]
Common stock, par value \| $ / shares							$ 0.0001	$ 0.0001
Proceeds from issuance of common stock \| $							$ 244,302
Common Shares \| shares							4,423,683	4,171,297
Issuance costs incurred, net proceeds \| $							$ 5,218	$ 0
K2 HealthVentures LLC Debt Conversion [Member]
Subsequent Event [Line Items]
Outstanding Loan \| $									$ 1,125,000
Common Shares \| shares									142,857
Conversion price per share \| $ / shares									$ 7.875
2014 Equity Incentive Plan [Member]
Subsequent Event [Line Items]
Percentage of outstanding common shares						7.00%
Shares available for future issuance \| shares											1,436,558
Shares available for future grants \| shares											741,870
May 2023 Sale Agreement [Member]
Subsequent Event [Line Items]
Authorized to offer and sell up of common stock \| $										$ 16,800,000
May 2023 Sale Agreement [Member] \| Jefferies LLC [Member]
Subsequent Event [Line Items]
Aggregate common stock sold, shares \| shares							14,106
Proceeds from issuance of common stock \| $							$ 114,000
Issuance costs incurred, net proceeds \| $							295,000
Maximum [Member] \| May 2023 Sale Agreement [Member] \| Jefferies LLC [Member]
Subsequent Event [Line Items]
Authorized to offer and sell up of common stock \| $							$ 16,800,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Market value of listed securities \| $	$ 35,000,000
Consecutive business days \| Days	10
Subsequent Event [Member] \| Jefferies LLC [Member]
Subsequent Event [Line Items]
Aggregate common stock sold, shares \| shares			4,325,000
additional shares of common stock \| shares			648,750
Common stock, par value \| $ / shares			$ 0.0001
Purchase price per share \| $ / shares			$ 19
Proceeds from issuance of common stock \| $		$ 94,500,000
Net Poceeds after deducting Underwriting Discounts and Commissions \| $		$ 88,500,000
Subsequent Event [Member] \| 2014 Equity Incentive Plan [Member]
Subsequent Event [Line Items]
Shares available for future issuance \| shares					1,746,215
Shares available for future grants \| shares					899,015
Subsequent Event [Member] \| 2014 Equity Incentive Plan [Member] \| Evergreen Provision [Member]
Subsequent Event [Line Items]
Increases in number of shares of common stock available for issuance, minimum percentage of outstanding common stock					7.00%
Increase in number of shares of common stock available for issuance \| shares					309,658
Percentage of outstanding common shares					7.00%
Shares available for future issuance \| shares					1,746,215
Shares available for future grants \| shares					899,015
Subsequent Event [Member] \| May 2023 Sale Agreement [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock \| $				$ 21,237,000
Authorized to offer and sell up of common stock \| $				$ 75,000,000